• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » MRI surgery devices maker launches IPO following name-change | Wall Street Beat

MRI surgery devices maker launches IPO following name-change | Wall Street Beat

May 30, 2012 By MassDevice staff

MassDevice.com Wall Street Beat

MRI Interventions (OTC:MRIC), a company developing minimally invasive neurosurgery systems, launched an initial public offering with shares at $1 apiece.

The Memphis-based company’s flagship ClearPoint technology allows patients to undergo surgery during MRI scanning, using the images to target areas of the brain for surgery.

The ClearPoint system includes durable equipment, such as a workstation monitor and patient fixation frame, as well as single-use instruments, and the device is already in use in 15 hospitals nationwide, the Memphis Business Journal reported.

The device maker was known as SurgiVision until just a couple of weeks ago when it announced its new moniker and re-launched its website, according to a press release.

"ClearPoint systems are installed at a growing number of hospitals, including many of the leading neurosurgical centers in the country," CEO Kimble Jenkins wrote in a recent note to stockholders. "We are making progress outside the US as well. At the end of last year, we completed our 1st installation in Europe and expect to open additional ClearPoint sites in Europe over the coming quarters."

Surgeons have used the ClearPoint system in treatment for a range of neurological diseases, including Parkinson’s disease, dystonia, pediatric dystonia, brain tumors, epilepsy and Tourette’s syndrome, Jenkins added.

MRI Interventions last month won FDA clearance for its SmartFlow neuro ventricular cannula, an MRI-compatible injection and aspiration cannula for use in the brain, according to a press release.

MRIC shares were down 1% to 98¢ as of about 9:30 a.m. today.

 Device makers could get hit by VA’s new prosthetics rules
The U.S. Dept. of Veterans Affairs is looking to curtail rising costs for medical prosthetics, which have increased 80% in the last 4 years, by changing how it purchases the devices and by requiring more documentation at the time of purchase.

That could take a toll on med-tech giants Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX), which collectively received $8 million for prosthetics from the VA in 2010, according to Bloomberg.
Read more

 Bioventus’ new CEO talks spinout
New Bioventus CEO Mark Augusti detailed his new company, which was formed when Smith & Nephew sold 51% of its biologics division to Essex Woodlands in a joint venture.

"Smith & Nephew felt that biologics was important and regenerative medicine was important for the future direction they wanted to play in, but they felt they couldn’t invest it appropriately," Augusti said. "There’s a real win-win here for the shareholders, an opportunity to monetize some of the current value in the business for Smith & Nephew shareholders, and that will probably only be 5% of the Smith & Nephew revenue, for Smith & Nephew to retain the minority position, the significant minority position, which should give them the window into biologics."
Read more

 Orthofix pairs up with Brainlab for spinal navigation systems
Orthofix (NSDQ:OFIX) and Brainlab reached an agrement to merge the Phoenix MIS and Firebird pedicle screw systems to form the latest generation of Brainlab spinal navigation technology.

The new systems aim to enhance minimally invasive spinal deformity surgery suing image-guided surgery platforms in conjunction with Orthofix’s spinal fixation systems.  
Read more

 Funding Roundup

  • SentreHeart raises $26M for Lariat(R) suture delivery systems
  • Kona Medical lands $30M for ultrasound high blood pressure therapy

 Analysts’ ups and downs

  • Intuitive Surgical (NSDQ:ISRG): J.P. Morgan raises price target from $500 to $570, maintains neutral price target
  • Stryker (NYSE:SYK): Zacks maintains "neutral" rating

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Bioventus LLC, Deals Roundup, Essex Woodlands Health Ventures, MRI Interventions, Orthofix, Smith & Nephew, U.S. Veterans Affairs Dept. (VA)

In case you missed it

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
  • Outset Medical wins national VA contract
  • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy

RSS From Medical Design & Outsourcing

  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy